Acupuncture Noncoverage Decisions Maintained By CMS Due To Poor Data
This article was originally published in The Gray Sheet
Executive Summary
Further evidence on the effect of sham versus real acupuncture for relief of osteoarthritis pain headlines a long list of research issues that need to be addressed before CMS reverses its noncoverage policy for the alternative therapy
You may also be interested in...
Placebo Effect Hinders Quality Of Chronic Pain Treatment Trials – FDA, CMS
Chronic pain therapy manufacturers must meet challenges presented by the placebo effect when designing clinical trials, according to FDA and CMS
Placebo Effect Hinders Quality Of Chronic Pain Treatment Trials – FDA, CMS
Chronic pain therapy manufacturers must meet challenges presented by the placebo effect when designing clinical trials, according to FDA and CMS
Osteoarthritis Acupuncture Evidence “Insufficient” – AHRQ Tech Assessment
Two randomized, controlled studies are being conducted to help determine whether a true benefit for acupuncture to treat osteoarthritis exists compared with placebo, according to an 1AHRQ tech assessment